The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksApax Global Alpha Regulatory News (APAX)

Share Price Information for Apax Global Alpha (APAX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 149.00
Bid: 148.00
Ask: 149.00
Change: 0.00 (0.00%)
Spread: 1.00 (0.676%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 149.00
APAX Live PriceLast checked at -
Apax Global Alpha is an Investment Trust

To provide shareholders with capital appreciation from our investment portfolio and regular dividends.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Quarterly Results for 31 March 2019

8 May 2019 07:00

RNS Number : 2923Y
Apax Global Alpha Limited
08 May 2019
 

(LSE: APAX)

 

 

Apax Global Alpha Limited

Quarterly results for the period ended 31 March 2019

 

For further information regarding the announcement of AGA's 2019 first quarter results, including the details for today's analyst and investor webcast at 9.30am (UK time), please visit www.apaxglobalalpha.com. 

 

 

Key highlights

 

· 1Q19 Total NAV Return1 was +8.7% (+6.5% constant currency)2. LTM3 Total NAV Return1 was +17.2% (+11.5% constant currency)2 reflecting strong performance of the Private Equity portfolio

· 2018 second semi-annual dividend of 4.12 pence was paid on 5 April 2019, equivalent to 2.5% of euro NAV at 31 December 2018

 

 

Outstanding commitments and funding sources

 

· AGA was 97% invested with net cash after liabilities of €28.0m4

· Outstanding commitments to the Apax Funds (together with recallable distributions) amounted to €259.2m (26% of NAV) with funding sources of €459.0m (46% of NAV). Funding sources comprise Derived Investments of €291.0m, undrawn facility of €140.0m, cash of €48.9m and net current liabilities of €20.9m

 

1Q19 performance highlights

 

· The contributions to Total NAV Return1 of +8.7% were: Private Equity +6.4%, Derived Investments +0.3%, FX +2.2% and costs and other movements -0.2%

· Derived Debt contributed +0.5% and Derived Equity -0.2% to Total NAV Return1

· Total Return1 of Private Equity was 12.3% (10.0% constant currency). Derived Debt delivered Total Return1 of 4.8% (2.5% constant currency). Derived Equity had a Total Return1 of 1.2% (-1.5% constant currency)

· Aggregate Gross IRR5 and Gross MOIC5 on Private Equity two full exits was 38.2% and 3.3x

· Gross IRR6 and Gross MOIC6 on one Derived Debt exit was 2.4% and 1.0x and on three Derived Equity exits was 36.5% and 1.3x 

 

Ralf Gruss, COO of Apax Partners, said:

 

"The strong operational momentum and strong exits of the Private Equity portfolio continued in the first quarter of 2019, translating into value accretion of the Invested Portfolio and strong performance for AGA."

 

Adjusted NAV7 movements

Private Equity

€m

Derived Investments

€m

Cash

 

€m

Facility drawn

€m

Other

 

€m

1Q19 Total

€m

LTM3

Total

€m

Adjusted NAV at 31.12.18

591.5

320.6

17.3

-

1.4

930.8

883.3

+ Investments

5.1

3.5

(10.4)

-

1.8

-

-

 - Divestments

(0.4)

(39.6)

40.6

-

(0.6)

-

-

+ Interest and dividend income

-

-

3.5

-

(0.1)

3.4

18.2

+/- Unrealised gains/(losses)

59.9

(3.0)

-

-

-

56.9

117.1

+/- Realised gains/(losses)

-

1.9

-

-

 

1.9

(22.7)

+/- FX gains/(losses)8

13.4

7.6

0.1

-

-

21.1

50.5

+/- Costs and other movements

-

-

(2.2)

-

0.3

(1.9)

(10.5)

 - Dividends paid

-

-

-

-

(23.7)

(23.7)

(47.4)

+/- Performance fee reserve

(0.3)

-

-

-

-

(0.3)

(0.3)

+/- Revolving credit facility

drawn/repaid

-

-

-

-

-

-

-

Adjusted NAV at 31.03.19

669.2

291.0

48.9

-

(20.9)

988.2

988.2

         

 

 

Private Equity portfolio highlights

 

· Private Equity portfolio delivered a strong performance with a Total Return1 of +12.3% (+10.0% constant currency)

· Unrealised gains were €59.9m and favourable FX movements were €13.4m

· On a look-through basis, AGA invested or committed c.€49.1m in three new companies

· Calls of €5.1m were paid to AIX (€3.1m), ADF (€1.8m) and AMI (€0.2m)

· Distribution of €0.4m to AGA from AMI in relation to Ten Petroleum and Max

· Aggregate Gross IRR5 and Gross MOIC5 on full exits was 38.2% and 3.3x

· FX exposure of c.51% in US dollar denominated investments

· Tech & Telco was the most heavily weighted sector, accounting for 38% of the Private Equity portfolio

· Private Equity portfolio is diversifying across fund vintages

 

Private Equity - operational metrics

31 March 2019

31 December 2018

Portfolio year-over-year LTM revenue growth9

13.0%

14.5%

Portfolio year-over-year LTM EBITDA growth9

14.2%

22.2%

Enterprise Value / EBITDA valuation multiple9

14.9x

14.5x

Net debt / EBITDA multiple9

3.9x

4.0x

Number of new investments in the quarter10

3

1

Number of exits in the quarter11

2

0

     

 

 

Derived Investments portfolio highlights

 

· A combination of Derived Debt Total Return1 of +4.8% (+2.5% constant currency) and Derived Equity Total Return1 of +1.2% (-1.5% constant currency) led to an overall Total Return1 of +3.2% for Derived Investments (+0.8% constant currency)

· Realised gains were €1.9m and unrealised losses of €3.0m stood against income of €3.4m and positive FX movements of €7.6m

· AGA had one add-on equity investment12 in QAD

· AGA exited one debt investment and three equities with proceeds of €39.6m13

· Gross IRR6 on Derived Debt exits was 2.4% and Gross MOIC6 was 1.0x. Gross IRR6 on Derived Equity exits was 36.5% and Gross MOIC6 was 1.3x

· FX exposure of c.62% in US dollar denominated investments

· Services was the most heavily weighted sector, accounting for 42% of the Derived Investments portfolio

· Portfolio split between Derived Debt and Derived Equity was 61% and 39% respectively

 

Derived Investments - operational metrics

 

31 March 2019

31 December 2018

Debt year-over-year LTM EBITDA growth14

 

10.6%

7.9%

Debt average income yield to maturity14

 

10.5%

10.6%

Debt average years to maturity

 

6.0

6.3

Debt average income yield15

 

10.2%

10.3%

Equity year-over-year LTM earnings growth16

 

16.0%

19.2%

Equity price-to-earnings ratio16

 

23.7x

18.5x

Number of investments in the quarter12

 

1

3

Number of full exits in the quarter13

 

4

6

 

 

 

Other Invested Portfolio highlights

 

· Exposures remained weighted towards Private Equity at 70% and Derived Investments of 30%

· FX exposure c.54% in US dollar denominated investments

 

 

Invested Portfolio analysis19

€m

€m

%

%

Private Equity

669.5

 

70%

 

- AMI

 

20.4

 

2%

- AEVI

 

5.5

 

1%

- AEVII

 

63.6

 

7%

- AVIII

 

380.0

 

40%

- AIX

 

193.8

 

 19%

- ADF

 

6.2

 

1%

Derived Investments

291.0

 

30%

 

- Derived Debt

 

178.9

 

18%

- Derived Equity

 

112.1

 

12%

Total

960.5

960.5

100%

100%

 

Sector mix

 

 

€m

Invested Portfolio19

%

Private

Equity

%

Derived Investments

%

Tech & Telco

 

36%

38%

31%

Services

 

29%

23%

42%

Healthcare

 

22%

22%

23%

Consumer

 

12%

16%

4%

Digital

 

1%

1%

0%

Other

 

0%

0%

0%

Total

960.5

100%

100%

100%

 

Geographic analysis

 

 

€m

Invested Portfolio19

%

Private

Equity

%

Derived Investments

%

North America

 

51%

49%

58%

Europe

 

27%

32%

12%

United Kingdom

 

8%

6%

14%

Israel

 

4%

5%

0%

India

 

7%

5%

12%

China

 

2%

2%

5%

Rest of World

 

1%

1%

0%

Total

960.5

100%

100%

100%

 

Summary of top 30 investments in Private Equity and Derived Investments

Valuation

€m

NAV

%

Top 30 Private Equity portfolio (look-through basis) - AGA's indirect exposure

 

 

AssuredPartners

 79.4

8%

Exact Software

 69.5

7%

ThoughtWorks

 47.9

5%

Cole Haan

 39.1

4%

Idealista

 38.0

4%

Acelity

 35.3

4%

Engineering

 34.6

4%

Unilabs

 34.2

3%

Vyaire Medical

 31.6

3%

Neuraxpharm

 29.9

3%

Duck Creek Technologies

 27.7

3%

EVRY

 26.4

3%

Paycor

 24.8

3%

Safetykleen

 20.2

2%

Candela

 19.5

2%

Wehkamp

 19.5

2%

MATCHESFASHION.COM

 18.8

2%

Quality Distribution

 16.8

2%

ECi Software Solutions

 16.1

1%

Shriram City Union

 14.0

1%

Tosca Services

 11.3

1%

Genius Sports Group

 9.5

1%

Guotai Junan Securities

 9.5

1%

Boats Group

 9.2

1%

Authority Brands

 8.9

1%

Attenti

 8.4

1%

Tivit

 7.9

1%

Healthium

 7.7

1%

Kepro

 7.4

1%

Psagot

 7.4

1%

Other (Other investments, carried interest, facility & non-current assets)

 (61.0)

(6%)

Total Private Equity

669.5

68%

 

 

 

Derived Investments portfolio

 

 

Paycor

 23.2

2%

Syncsort

 22.3

2%

KRKA

 20.4

2%

Rocket Software

 17.8

2%

Quality Distribution

 17.7

2%

Vyaire Medical

 16.3

2%

PowerSchool

 13.5

1%

ECi Software Solutions

 13.4

1%

Sinopharm

 13.2

1%

Alexander Mann

 12.9

1%

Development Credit Bank

 12.3

1%

Safetykleen

 10.0

1%

QAD

 9.6

1%

Lonza

 9.2

1%

PDC Brands

 9.0

1%

LegalShield

 8.9

1%

Sophos

 8.3

1%

Strides Pharma Science

 8.0

1%

Repco Home Finance

 7.9

1%

Just Group

 7.4

1%

CanFin Homes

 6.9

1%

Boats Group

 6.5

1%

Veritext

 4.5

1%

EVRY

 4.0

0%

Answers

 1.9

0%

ERM

 1.8

0%

Cengage Learning

 1.2

0%

Solara

 1.2

0%

Fullbeauty (new 2L debt)

 1.1

0%

Fullbeauty (equity)

 0.5

0%

 

 

 

Total Derived Investments

291.0

29%

 

 

 

Total Invested Portfolio17

960.5

97%

Cash

48.9

5%

Revolving credit facility drawn

0.0

0%

Net current liabilities

(20.9)

(2%)

Total NAV

988.5

100%

Performance fee reserve

(0.3)

 

Total Adjusted NAV

988.2

 

 

For more information, the Company's quarterly results presentation is available to view at: www.apaxglobalalpha.com 

 

 

 

Contact details

Investor enquiries

Media enquiries

Sarah Wojcik

IR Manager - AGA

Andrew Kenny

Head of Communications

Telephone: +44 (0)20 7666 6573

Telephone: +44 (0) 20 7872 6371

Email: sarah.wojcik@apax.com

Email: andrew.kenny@apax.com

 

 

 

 

Footnotes

 

1. Total NAV Return means the movement in the Adjusted NAV per share over the period plus any dividends paid. Total Return reflects the sub-portfolio performance on a stand-alone basis. It excludes items at overall AGA level such as cash, management fees and costs

2. Constant currency returns calculated the same as Total NAV Return adjusted to remove the impact of FX

3. LTM = Last Twelve Months to 31 March 2019

4. Net cash after liabilities of €28.0m calculated by taking cash of €48.9 less net current liabilities of €20.9m at 31 March 2019

5. Aggregate Gross IRR and Gross MOIC on full exits calculated based on the expected aggregate cash flows in euro across all funds for the deals transacted in the period; Exact and Assured Partners were signed in 1Q19 and are expected to close in 2Q19 and Gross IRR and MOIC are subject to change once final proceeds have been received. Gross IRR represents concurrent Gross IRR

6. Gross IRR and Gross MOIC calculated based on aggregate euro cash flows since inception of deals realised during the year

7. Adjusted NAV represents NAV of €988.2m adjusted for the performance fee reserve of €0.3m at 31 March 2019

8. FX on cash includes the revaluation of cash balances and net losses arising from the differences in exchange rates between transaction dates and settlement dates, and unrealised net losses arising from the translation into euro of assets and liabilities (other than investments) which are not denominated in euro

9. At December 2018 and March 2019, 13 and 15 investments were respectively excluded as these are financial services companies often valued on book value or for which earnings financials are not available e.g. complex carve-outs or growth investments. Net debt/EBITDA multiple and EV/EBITDA valuation multiple excludes MatchesFashion and Vyaire Medical due to low EBITDA from opex investments and short-term fluctuations in EBITDA respectively

10. New investments in the first three months of 2019. Fractal closed in February 2019; Trade Me signed in December 2018 and AssuredPartners signed in February 2019 with both expected to close in 2Q19

11. Represents exits which were signed but not yet closed in the first three months of 2019. Both AssuredPartners and Exact signed in February 2019 and are expected to close in 2Q19

12. There was one add-on equity position (QAD) and no new purchases in the period. FullBeauty second lien debt restructured in the period and in lieu of this AGA received new second lien debt, equity and warrants. These have been excluded from the sales and purchases above

13. One debt position and three equity positions were fully realised in 1Q19. Additionally, FullBeauty second lien debt restructured in the period and in lieu of this AGA received new second lien debt, equity and warrants. These have been excluded from the sales and purchases above

14. Gross Asset Value weighted average of the respective metric across the Derived Investments Debt portfolio

15. Gross Asset Value weighted average of the current full year income (annual coupon/clean price as at the respective date) for each debt position in the Derived Debt portfolio as at the respective date

16. Gross Asset Value weighted average of the respective metric across the Derived Investments Equity portfolio. (Cengage and QAD were excluded from both LTM earnings growth and P/E ratio due to negative earnings and Answers and Solara were excluded as information was not available)

17. Invested Portfolio excludes cash and cash equivalents, revolving credit facility drawn and net current assets; including these, the NAV is €988.5m. Adjusted NAV excludes the performance fee reserve of €0.3m and is €988.2m at 31 March 2019

 

 

Notes

 

1. Note that references in this announcement to Apax Global Alpha Limited have been abbreviated to "AGA" or "the Company". References to Apax Partners LLP have been abbreviated to "Apax Partners" or "the Investment Adviser"

2. Please be advised that this announcement may contain inside information as stipulated under the Market Abuse Regulations (EU) NO. 596/2014 ("MAR")

3. This announcement is not for release, publication or distribution, directly or indirectly, in whole or in part, into or within the United States or to "US persons" (as defined in Regulation S under the United States Securities Act of 1933, as amended (the "Securities Act")) or into or within Australia, Canada, South Africa or Japan. Recipients of this announcement in jurisdictions outside the UK should inform themselves about and observe any applicable legal requirements in their jurisdictions. In particular, the distribution of the announcement may be restricted by law in certain jurisdictions

4. The information presented herein is not an offer for sale within the United States of any equity shares or other securities of Apax Global Alpha Limited ("AGA"). AGA has not been and will not be registered under the US Investment Company Act of 1940, as amended (the "Investment Company Act"). In addition, AGA's shares (the "Shares") have not been and will not be registered under the Securities Act or any other applicable law of the United States. Consequently, the Shares may not be offered or sold or otherwise transferred within the United States, or to, or for the account or benefit of, US Persons, except pursuant to an exemption from the registration requirements of the Securities Act and under circumstances which will not require AGA to register under the Investment Company Act. No public offering of the Shares is being made in the United States

5. This announcement may include forward-looking statements. The words "expect", "anticipate", "intends", "plan", "estimate", "aim", "forecast", "project" and similar expressions (or their negative) identify certain of these forward-looking statements. These forward-looking statements are statements regarding AGA's intentions, beliefs or current expectations concerning, among other things, AGA's results of operations, financial condition, liquidity, prospects, growth and strategies. The forward-looking statements in this presentation are based on numerous assumptions regarding AGA's present and future business strategies and the environment in which AGA will operate in the future. Forward-looking statements involve inherent known and unknown risks, uncertainties and contingencies because they relate to events and depend on circumstances that may or may not occur in the future and may cause the actual results, performance or achievements of AGA to be materially different from those expressed or implied by such forward looking statements. Many of these risks and uncertainties relate to factors that are beyond AGA's ability to control or estimate precisely, such as future market conditions, currency fluctuations, the behaviour of other market participants, the actions of regulators and other factors such as AGA's ability to continue to obtain financing to meet its liquidity needs, changes in the political, social and regulatory framework in which AGA operates or in economic or technological trends or conditions. Past performance should not be taken as an indication or guarantee of future results, and no representation or warranty, express or implied, is made regarding future performance. AGA expressly disclaims any obligation or undertaking to release any updates or revisions to these forward-looking statements to reflect any change in AGA's expectations with regard thereto or any change in events, conditions or circumstances on which any statement is based after the date of this announcement, or to update or to keep current any other information contained in this announcement. Accordingly, undue reliance should not be placed on the forward-looking statements, which speak only as of the date of this announcement

 

 

About Apax Global Alpha Limited

 

AGA is a Guernsey registered closed-ended collective investment scheme incorporated as a non-cellular company that listed on the London Stock Exchange on 15 June 2015. It is regulated by the Guernsey Financial Services Commission.

 

AGA's objective is to provide shareholders with capital appreciation from its investment portfolio and regular dividends. The Company is targeting an annualised Total Return, across economic cycles, of 12-15% (net of fees and expenses) including a dividend yield of 5% of Net Asset Value.

 

The investment policy of the Company is to make Private Equity investments in Apax Funds, and Derived Investments which are investments in equities and debt derived from the insights gained via Apax Partners' Private Equity activities. The Company's portfolio is expected to be allocated in approximately equal proportions between Private Equity and Derived Investments, although the investment mix will fluctuate over time due to market conditions, investment opportunities, cash flow requirements, the dividend policy and other factors. Further information regarding the Company and its publications are available on the Company's website at www.apaxglobalalpha.com.

 

 

About Apax Partners LLP

 

Apax Partners is a leading global private equity advisory firm and over its more than 40-year history, Apax Partners has raised and advised funds with aggregate commitments of c.€40 billion as at 31 March 2019. Funds advised by Apax Partners invest in companies across four global sectors of Tech & Telco, Services, Healthcare and Consumer. These funds provide longterm equity financing to build and strengthen worldclass companies. For further information about Apax Partners, please visit www.apax.com.

 

Apax Partners is authorised and regulated by the Financial Conduct Authority in the UK.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
QRFVDLFBKEFZBBX
Date   Source Headline
13th Mar 20196:05 pmRNSDirector/PDMR Shareholding
5th Mar 20197:00 amRNSUpdated Key Information Document
5th Mar 20197:00 amRNS2018 Annual Dividend
5th Mar 20197:00 amRNS2018 Annual Report and Accounts
5th Mar 20197:00 amRNS2018 Final Results
26th Feb 201911:42 amRNSExits from Exact Software and AssuredPartners
29th Jan 20197:00 amRNSApax Funds' Valuations as at 31 December 2018
21st Dec 20181:48 pmRNSDirector/PDMR Shareholding
21st Dec 201812:09 pmRNSInclusion in FTSE 250 Index
19th Dec 20186:30 pmRNSShire
27th Nov 201810:00 amRNSPDMR Dealing - Share Transfers
23rd Nov 20183:07 pmRNSDirector Dealings - Chris Ambler
14th Nov 20187:00 amRNSNotice of Annual Results
7th Nov 20187:00 amRNSNew revolving credit facility
7th Nov 20187:00 amRNSQuarterly results for the period ended 30 Sep 2018
13th Sep 20184:29 pmRNSDirector Dealings - Chris Ambler
5th Sep 20185:12 pmRNSNotice of Quarterly Results 30 Sept 2018
14th Aug 20187:00 amRNS2018 Interim Dividend
14th Aug 20187:00 amRNS2018 Interim Results Highlights
14th Aug 20187:00 amRNS2018 Interim Report and Accounts
31st Jul 20187:00 amRNSApax Funds' Valuations as at 30 June 2018
18th Jul 20183:00 pmRNSHolding(s) in Company
3rd Jul 201810:00 amRNSDirectorate Change
2nd Jul 20183:00 pmRNSDirector Declaration
14th Jun 20187:00 amRNSNotice of Interim Results 2018
6th Jun 20187:00 amRNSAGA Investor Day
23rd May 201810:00 amRNSEU GDPR Data Privacy Notices
3rd May 20187:00 amRNSQuarterly results for 31 March 2018
1st May 20183:04 pmRNSResult of AGM
26th Apr 201812:47 pmRNSDirectorate Change
16th Apr 20187:25 amRNSNotice of Investor Day
19th Mar 20184:46 pmRNSDirector Declaration
19th Mar 201812:00 pmRNSNotice of AGM
14th Mar 20182:45 pmRNSNotice of Quarterly Results Q1 2018
6th Mar 20187:00 amRNS2017 Annual Dividend Announcement
6th Mar 20187:00 amRNSUpdated Key Information Document
6th Mar 20187:00 amRNS2017 Final Results
6th Mar 20187:00 amRNS2017 Annual Report and Accounts
31st Jan 20185:25 pmRNSDirector/PDMR Shareholding
30th Jan 20187:00 amRNSApax Funds' Valuations as at 31 December 2017
4th Jan 20185:09 pmRNSDirectorate Change - Sarah Evans
2nd Jan 201812:00 pmRNSPublication of Key Information Document
15th Dec 20172:06 pmRNSHolding(s) in Company
6th Nov 20177:00 amRNSNotice of Annual Results
1st Nov 20177:00 amRNSQ3 2017 Results Highlights
11th Sep 20177:00 amRNS3Q17 Financial Highlights
31st Aug 20172:57 pmRNSAGA's FTSE Index Inclusion
17th Aug 20177:00 amRNS2017 Interim Dividend
17th Aug 20177:00 amRNS2017 Interim Report and Accounts
17th Aug 20177:00 amRNS2017 Interim Results Highlights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.